DSM Biomedical; Filing of Color Additive Petition, 77467 [2024-21684]

Download as PDF Federal Register / Vol. 89, No. 184 / Monday, September 23, 2024 / Proposed Rules Issued on September 10, 2024. Victor Wicklund, Deputy Director, Compliance & Airworthiness Division, Aircraft Certification Service. [FR Doc. 2024–21652 Filed 9–20–24; 8:45 am] BILLING CODE 4910–13–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 74 DSM Biomedical; Filing of Color Additive Petition Notification of petition. Kalle L. Wardlow, Federal Register Liaison, Publications & Regulations Section, Associate Chief Counsel, (Procedure and Administration). khammond on DSKJM1Z7X2PROD with PROPOSALS DEPARTMENT OF THE TREASURY The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by DSM Biomedical, proposing that the color additive regulations be amended to provide for the safe use of phthalocyanine green to color surgical sutures made of ultra-high molecular weight polyethylene (UHMWPE) for use in general surgery, at a concentration of no more than 0.5 percent by weight of the suture. DATES: The color additive petition was filed on August 15, 2024. ADDRESSES: For access to the docket to read background documents or comments received, go to https:// www.regulations.gov and insert the docket number found in brackets in the heading of this document into the ‘‘Search’’ box and follow the prompts, and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Stephen DiFranco, Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240–402–2710. SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic Act (section 721(d)(1) (21 U.S.C. 379e(d)(1))), we are giving notice that we have filed a color additive petition (CAP 4C0335), submitted by DSM Biomedical, 735 Pennsylvania Dr., Exton, PA 19341. The petition proposes to amend the color additive regulations in 21 CFR part 74, ‘‘Listing of Color Additives Subject to Certification,’’ to provide for the safe use of phthalocyanine green to color surgical sutures made of UHMWPE for use in general surgery, at a concentration of no SUMMARY: VerDate Sep<11>2014 15:56 Sep 20, 2024 Jkt 262001 Correction Internal Revenue Service (IRS), Treasury. ACTION: Notice of proposed rulemaking; correction. BILLING CODE 4164–01–P HHS. ACTION: The notice of proposed rulemaking (REG–108920–24) that is the subject of this correction is under section 48E of the Internal Revenue Code. Guidance on Clean Electricity LowIncome Communities Bonus Credit Amount Program; Correction [FR Doc. 2024–21684 Filed 9–20–24; 8:45 am] Food and Drug Administration, Background Accordingly, FR Doc. 2024–19617 (REG–108920–24), appearing on page 71193 in the Federal Register on Tuesday, September 3, 2024, is corrected as follows: 1. On page 71195, in the third column, in the first full paragraph, by correcting the fourth line from the top of the paragraph to read, ‘‘most recently released by American Community Survey (ACS) low-income’’. 2. On page 71196, in the second column, in the sixth bullet point from the top of the page, by correcting the first line of the bullet point to read, ‘‘Department of Agriculture (USDA) Section 515 Rural Rental’’. 3. On page 71204, in the third column, in the fourth full paragraph, by correcting the fifth sentence from the top of the paragraph to read, ‘‘records are required for the IRS to validate’’. 4. On page 71206, in the second column, in the third full paragraph, by correcting the twelve line from the top of the paragraph to read ‘‘The proposed regulations do not have substantial’’. Dated: September 18, 2024. Lauren K. Roth, Associate Commissioner for Policy. [Docket No. FDA–2024–C–4339] AGENCY: more than 0.5 percent by weight of the suture. The petitioner claims that this action is categorically excluded under 21 CFR 25.32(l) because the substance is used in sutures. If FDA determines a categorical exclusion applies, neither an environmental assessment nor an environmental impact statement is required. If FDA determines a categorical exclusion does not apply, we will request an environmental assessment and make it available for public inspection. 77467 Internal Revenue Service 26 CFR Part 1 [REG–108920–24] RIN 1545–BR26 AGENCY: This document contains corrections to REG–108920–24, which was published in the Federal Register on Tuesday, September 3, 2024. REG– 108920–24 contained proposed regulations concerning the program to allocate clean electricity low-income communities bonus credit amounts established pursuant to the Inflation Reduction Act of 2022 for calendar years 2025 and succeeding years. DATES: Written or electronic comments and requests for a public hearing must be received by October 3, 2024. ADDRESSES: Commenters were strongly encouraged to submit public comments electronically. FOR FURTHER INFORMATION CONTACT: Concerning the proposed rules, Office of Associate Chief Counsel (Passthroughs & Special Industries) at (202) 317–6853 (not a toll-free number); concerning submissions of comments or the public hearing, the Publications and Regulations Section at (202) 317–6901 (not a toll-free number) or by email at publichearings@irs.gov (preferred). SUPPLEMENTARY INFORMATION: SUMMARY: PO 00000 Frm 00011 Fmt 4702 Sfmt 4702 [FR Doc. 2024–21639 Filed 9–20–24; 8:45 am] BILLING CODE 4830–01–P ENVIRONMENTAL PROTECTION AGENCY 40 CFR Part 52 [EPA–R09–OAR–2024–0418; FRL–12225– 01–R9] Air Plan Revisions; California; San Diego County Air Pollution Control District and Mojave Desert Air Quality Management District Environmental Protection Agency (EPA). ACTION: Proposed rule. AGENCY: The Environmental Protection Agency (EPA) is proposing to approve revisions to the San Diego County Air Pollution Control District (SDCAPCD) and Mojave Desert Air Quality Management District (MDAQMD) portions of the California State Implementation Plan (SIP). These revisions concern negative declarations for the Control Techniques Guidelines SUMMARY: E:\FR\FM\23SEP1.SGM 23SEP1

Agencies

[Federal Register Volume 89, Number 184 (Monday, September 23, 2024)]
[Proposed Rules]
[Page 77467]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21684]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 74

[Docket No. FDA-2024-C-4339]


DSM Biomedical; Filing of Color Additive Petition

AGENCY: Food and Drug Administration, HHS.

ACTION: Notification of petition.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is announcing 
that we have filed a petition, submitted by DSM Biomedical, proposing 
that the color additive regulations be amended to provide for the safe 
use of phthalocyanine green to color surgical sutures made of ultra-
high molecular weight polyethylene (UHMWPE) for use in general surgery, 
at a concentration of no more than 0.5 percent by weight of the suture.

DATES: The color additive petition was filed on August 15, 2024.

ADDRESSES: For access to the docket to read background documents or 
comments received, go to https://www.regulations.gov and insert the 
docket number found in brackets in the heading of this document into 
the ``Search'' box and follow the prompts, and/or go to the Dockets 
Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Stephen DiFranco, Center for Food 
Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus 
Dr., College Park, MD 20740, 240-402-2710.

SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic 
Act (section 721(d)(1) (21 U.S.C. 379e(d)(1))), we are giving notice 
that we have filed a color additive petition (CAP 4C0335), submitted by 
DSM Biomedical, 735 Pennsylvania Dr., Exton, PA 19341. The petition 
proposes to amend the color additive regulations in 21 CFR part 74, 
``Listing of Color Additives Subject to Certification,'' to provide for 
the safe use of phthalocyanine green to color surgical sutures made of 
UHMWPE for use in general surgery, at a concentration of no more than 
0.5 percent by weight of the suture.
    The petitioner claims that this action is categorically excluded 
under 21 CFR 25.32(l) because the substance is used in sutures. If FDA 
determines a categorical exclusion applies, neither an environmental 
assessment nor an environmental impact statement is required. If FDA 
determines a categorical exclusion does not apply, we will request an 
environmental assessment and make it available for public inspection.

    Dated: September 18, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-21684 Filed 9-20-24; 8:45 am]
BILLING CODE 4164-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.